Neurological Diseases alzheimers Flashcards

(28 cards)

1
Q

what is dementia defined as
some exapmles

A

progressive deterioration of cognitive function
short term memory loss
long term memory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is AD different from dementia

A

rapid cognitive decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the clinical symptoms of AD

A

memory loss
abnormal behavouir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the main risk factor for AD

A

age
incidence doubles every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how many people have dementia in the uk and how much does this cost the healthcare system

A

over 500 thousand
costs 35 billion a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the pathological hallmarks of AD

A

amyloid plaques
intracellular neurofibrillary tangle
non fungible tokes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

between the two hallmarks of AD
which is intracellular and which is extracellular

A

amyloid plaques are extracellular and nfts are intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are some of the theories behind AD pathogenesis

A

amyloid cascade hypothesis
tau and tangle hypothesis
mitochondrial dysfunction and ox stress hypothesis
cholinergic hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the app in AD

A

large extracellular protein produced in large quantities in neurons
undergoes post translational processing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the three secretases involved in the cleavage of app in AD

A

alpha beta and gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the two product catagories of amyloid secretases

A

pathogenic and non pathogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which two secretases cleave app in non AD

A

alpha and gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the products formed by alpha secretase in the non amyloid in AD

A

alpha cleaves app to create soluble appa(released)
membrane associated c terminal fragment actf(c83)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the products formed by gamma secretase in non amyloid

A

gamma cleaves acft to make p3
and aicd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the products formed in the amyloid process in AD

A

sappb
c terminal fragment beta(c99)

gamma secretase then cleaves beta cft to form beta amyloid peptide and aicd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why do beta amyloid peptides cause AD

A

increased formation and defectiv clearance of beta amyloid causes plaques
beta amyloid is neurotoxic

17
Q

what causes familal AD

A

mutations in app or secretases cause AD

18
Q

what are nfts formed from

A

intracellular aggregates of tau protein

19
Q

what is the tau protein in AD

A

a microtubule associated protein
promotes microtubule assembly
and maintains stability

20
Q

how is the binding of tau to microtubules mediated in AD

A

phosphorylation state

21
Q

what does hyperphosphorylation do to tau in AD

A

decreases its binding to microtubules
decreased binding leads to tau aggregation
causes confirmational changes and misfolds in protein structure

22
Q

what is cholinergic hypothesis for ad

A

the reduction in acetylcholine release leads to AD

23
Q

in AD why is there a reduction of ach synthesis

A

deficit in enzyme
ChAT choline acetyl transferase

reduction of ach in neuron depolarisation

reduction of ach reuptake

loss of cholinergic neurones

24
Q

what is the reasoning behind mitochondrial dysfunction theory of ad

A

dysfunction increases with age
which leads to compromised atp production and oxidative stress
contributes to neuronal death

25
what are the two main drug classes used to treat ad
cholinesterase inhibitors nmda receptor antagonist(MDMA) cholinomimetic therapy acetylcholinesterase inhibitors
26
what to acetylcholinesterases inhibitors do
prevent breakdown of ACH increase concentration increase communication
27
what neurotransmitter is released in later stages of AD
glutamate
28
what can glutamate do in ad and which drug class counters this
can cause further damage NMDA blocks glutamate